Aytu BioPharma, Inc.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2018
Total Assets: $21.1M
Liabilities Breakdown FY2018
Total Liabilities: $7.6M
Asset Breakdown
Total Assets: $21.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.0M | 33.3% |
| Accounts Receivable | $578.8K | 2.7% |
| Inventory | $1.3M | 6.4% |
| Property, Plant & Equipment | $218.7K | 1.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $245.9K | 1.2% |
| Other Assets | $11.7M | 55.4% |
Liabilities Breakdown
Total Liabilities: $7.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 27.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.5M | 72.2% |